Da Hee Han, PharmD

Most Recent Articles by Da Hee Han, PharmD

Lenvima OK'd as First-Line Treatment for Unresectable Hepatocellular Carcinoma

By Aug 16, 2018

The approval was supported by findings from the multicenter, randomized, open-label, noninferiority trial, REFLECT (N=945), which included patients with previously untreated, metastatic or unresectable HCC.

FDA Approves Cequa for the Treatment of Dry Eye Disease

By Aug 16, 2018

Cequa was evaluated in 2 multicenter, randomized studies involving 1,048 patients with dry eye disease.

Prevalence of Antimicrobial-Contraindicated Drug Combo Prescribing Examined

By Aug 16, 2018

Researchers performed a cross-sectional study that included multiple year pooled data (2003 to 2011) from the National Ambulatory Medical Care Survey (NAMCS) and the National Hospital Ambulatory Medical Care Survey (NHAMCS Outpatient Department).

Iclaprim Gets Priority Review for Acute Bacterial Skin/Skin Structure Infections

By Aug 15, 2018

Clinical data has indicated that the drug exhibits a low propensity for resistance development as well as a favorable tolerability profile.

Labeling for Several HIV Meds Updated to Include Interaction Data With DOACs

By Aug 14, 2018

If Tybost is given with atazanavir or darunavir, coadministration with rivaroxaban is not recommended due to a potentially increased bleeding risk.

More Articles by Da Hee Han, PharmD